These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32041772)

  • 41. Prevalence of HIV infection among tuberculosis patients in Eastern India.
    Manjareeka M; Nanda S
    J Infect Public Health; 2013 Oct; 6(5):358-62. PubMed ID: 23999356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting.
    Jørstad MD; Dyrhol-Riise AM; Aßmus J; Marijani M; Sviland L; Mustafa T
    BMC Infect Dis; 2019 May; 19(1):426. PubMed ID: 31096926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
    PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding.
    Balcha TT; Skogmar S; Sturegård E; Björkman P; Winqvist N
    Glob Health Action; 2015; 8():27048. PubMed ID: 25819037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis.
    Lieberman TD; Wilson D; Misra R; Xiong LL; Moodley P; Cohen T; Kishony R
    Nat Med; 2016 Dec; 22(12):1470-1474. PubMed ID: 27798613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
    Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
    Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi.
    Kumwenda M; Tom S; Chan AK; Mwinjiwa E; Sodhi S; Joshua M; van Lettow M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1663-9. PubMed ID: 22118175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia.
    Sahle SN; Asress DT; Tullu KD; Weldemariam AG; Tola HH; Awas YA; Hagos GG; Worku MG; Misgina DK
    BMC Res Notes; 2017 Jan; 10(1):74. PubMed ID: 28137314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tuberculous Pericardial Effusions in Children.
    Obihara NJ; Walters E; Lawrenson J; Garcia-Prats AJ; Hesseling AC; Schaaf HS
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):346-349. PubMed ID: 29096017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi.
    Bong CN; Chen SC; Jong YJ; Tok TS; Hsu CF; Schouten EJ; Makombe SD; Yu JK; Harries AD
    Int J Tuberc Lung Dis; 2007 May; 11(5):534-8. PubMed ID: 17439677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
    Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
    Mbu ET; Sauter F; Zoufaly A; Bronsvoort BMC; Morgan KL; Noeske J; Abena JF; Sander MS
    PLoS One; 2018; 13(6):e0199634. PubMed ID: 29944701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units.
    Benjamin A; Cavalcante SC; Jamal LF; Arakaki-Sanchez D; de Lima JN; Pilotto JH; de Oliveira Junior FI; Souza TNL; Lourenço MC; de Mello MB; do Brasil PEAA; Barreira D; Rolla V
    PLoS One; 2019; 14(9):e0221038. PubMed ID: 31550246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi.
    Harries AD; Nyangulu DS; Kang'ombe C; Ndalama D; Glynn JR; Banda H; Wirima JJ; Salaniponi FM; Liomba G; Maher D; Nunn P
    Trans R Soc Trop Med Hyg; 1998; 92(3):343-7. PubMed ID: 9861414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
    Azeez A; Mutambayi R; Odeyemi A; Ndege J
    Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients.
    Huerga H; Cossa L; Manhiça I; Bastard M; Telnov A; Molfino L; Sanchez-Padilla E
    Am J Trop Med Hyg; 2020 Mar; 102(3):562-566. PubMed ID: 31971152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Focused assessment with sonography for HIV-associated tuberculosis (FASH): a short protocol and a pictorial review.
    Heller T; Wallrauch C; Goblirsch S; Brunetti E
    Crit Ultrasound J; 2012 Nov; 4(1):21. PubMed ID: 23171481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.